Inicio > BIGG > Resultado de la búsqueda

    Resultados: 2

    American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015: recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis

    Ward, M. M; Deodhar, A; Akl, E. A; Lui, A; Ermann, J; Gensler, L. S; Smith, J. A; Borenstein, D; Hiratzka, J; Weiss, P. F; Inman, R. D; Majithia, V; Haroon, N; Maksymowych, W. P; Joyce, J; Clark, B. M; Colbert, R. A; Figgie, M. P; Hallegua, D. S; Prete, P. E; Rosenbaum, J. T; Stebulis, J. A; Bosch, F van den; Yu, D. T; Miller, A. S; Reveille, J. D; Caplan, L.
    Arthritis rheumatol; 68 (2), 2016
    OBJECTIVE: To provide evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). METHODS: A core group led the development of the recommendations, starting with the treatment questions. A literature review group conduct...
    Espondilitis Anquilosante/tratamiento farmacológico, Espondiloartritis/tratamiento farmacológico, Antiinflamatorios no Esteroideos/uso terapéutico, Antirreumáticos/uso terapéutico, Glucocorticoides/uso terapéutico, Factor de Necrosis Tumoral alfa/uso terapéutico, Infliximab/uso terapéutico, Adalimumab/uso terapéutico, Etanercept/uso terapéutico, Modalidades de Fisioterapia, Espondilitis Anquilosante/terapia
    Texto completo

    American Gastroenterological Association Institute Guideline on the Use of Thiopurines, Methotrexate, and Anti–TNF-α Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease

    Terdiman, JP; Gruss, CB; Heidelbaugh, JJ; Sultan, S; Falck-Ytter, YT.
    Gastroenterology; 145 (6), 2013
    Factor de Necrosis Tumoral alfa, Mercaptopurina, Azatioprina, Metotrexato, Enfermedad de Crohn, Gastroenterología, Mercaptopurina/uso terapéutico, Metotrexato/uso terapéutico, Inducción de Remisión, Enfermedad de Crohn/tratamiento farmacológico, Factor de Necrosis Tumoral alfa/antagonistas & inhibidores
    Texto completo